Annual Long Term Debt
$68.08 M
-$4.77 M-6.55%
31 December 2023
Summary:
Iovance Biotherapeutics annual long term debt is currently $68.08 million, with the most recent change of -$4.77 million (-6.55%) on 31 December 2023. During the last 3 years, it has risen by +$22.71 million (+50.05%). IOVA annual long term debt is now -6.55% below its all-time high of $72.86 million, reached on 31 December 2022.IOVA Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Debt
$67.39 M
-$2.86 M-4.07%
30 September 2024
Summary:
Iovance Biotherapeutics quarterly long term debt is currently $67.39 million, with the most recent change of -$2.86 million (-4.07%) on 30 September 2024. Over the past year, it has dropped by -$1.62 million (-2.35%). IOVA quarterly long term debt is now -8.93% below its all-time high of $74.00 million, reached on 30 June 2022.IOVA Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IOVA Long Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -6.5% | -2.4% |
| 3 y3 years | +50.0% | +2.5% |
| 5 y5 years | +100.0% | +1020.0% |
IOVA Long Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -6.5% | +50.0% | -8.9% | +2.5% |
| 5 y | 5 years | -6.5% | -8.9% | +3267.8% | |
| alltime | all time | -6.5% | -8.9% |
Iovance Biotherapeutics Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $67.39 M(-4.1%) |
| June 2024 | - | $70.25 M(-4.2%) |
| Mar 2024 | - | $73.29 M(+7.6%) |
| Dec 2023 | $68.08 M(-6.6%) | $68.08 M(-1.3%) |
| Sept 2023 | - | $69.01 M(-1.2%) |
| June 2023 | - | $69.84 M(-1.1%) |
| Mar 2023 | - | $70.61 M(-3.1%) |
| Dec 2022 | $72.86 M(+9.6%) | $72.86 M(-0.1%) |
| Sept 2022 | - | $72.94 M(-1.4%) |
| June 2022 | - | $74.00 M(+2.5%) |
| Mar 2022 | - | $72.18 M(+8.6%) |
| Dec 2021 | $66.47 M | $66.47 M(+1.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2021 | - | $65.73 M(+37.4%) |
| June 2021 | - | $47.84 M(-0.5%) |
| Mar 2021 | - | $48.08 M(+6.0%) |
| Dec 2020 | $45.38 M(+968.1%) | $45.38 M(+1122.7%) |
| Sept 2020 | - | $3.71 M(+85.5%) |
| June 2020 | - | $2.00 M(-35.2%) |
| Mar 2020 | - | $3.09 M(-27.3%) |
| Dec 2019 | $4.25 M(>+9900.0%) | $4.25 M(-29.4%) |
| Sept 2019 | - | $6.02 M(+30.4%) |
| June 2019 | - | $4.61 M(+5.3%) |
| Mar 2019 | - | $4.38 M(>+9900.0%) |
| Dec 2018 | $0.00 | $0.00 |
FAQ
- What is Iovance Biotherapeutics annual long term debt?
- What is the all time high annual long term debt for Iovance Biotherapeutics?
- What is Iovance Biotherapeutics annual long term debt year-on-year change?
- What is Iovance Biotherapeutics quarterly long term debt?
- What is the all time high quarterly long term debt for Iovance Biotherapeutics?
- What is Iovance Biotherapeutics quarterly long term debt year-on-year change?
What is Iovance Biotherapeutics annual long term debt?
The current annual long term debt of IOVA is $68.08 M
What is the all time high annual long term debt for Iovance Biotherapeutics?
Iovance Biotherapeutics all-time high annual long term debt is $72.86 M
What is Iovance Biotherapeutics annual long term debt year-on-year change?
Over the past year, IOVA annual long term debt has changed by -$4.77 M (-6.55%)
What is Iovance Biotherapeutics quarterly long term debt?
The current quarterly long term debt of IOVA is $67.39 M
What is the all time high quarterly long term debt for Iovance Biotherapeutics?
Iovance Biotherapeutics all-time high quarterly long term debt is $74.00 M
What is Iovance Biotherapeutics quarterly long term debt year-on-year change?
Over the past year, IOVA quarterly long term debt has changed by -$1.62 M (-2.35%)